Apex Trader Funding - News
Johnson & Johnson Nears Approval for $6.5B Long Standing Talc Settlement
Johnson & Johnson (NYSE:JNJ) is expected to confirm a $6.48 billion settlement plan to resolve thousands of lawsuits alleging that its baby powder products cause cancer.
What Happened: Reuters noted that the company will reveal Friday that over 75% of claimants have agreed to the settlement. This surpasses the threshold required for a judge to approve the proposed bankruptcy plan.
A Johnson & Johnson subsidiary will file for bankruptcy protection to finalize the settlement.
Also Read: Medicare Costs For Johnson & Johnson’s ...